SCHEMBL17152001

SCHEMBL17152001

CC1(C)c2ccccc2-c2cc(-c3c(-c4nc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccc(-c6ccccc6)cc5)n4)c4ccccc4c4ccccc34)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 5/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
ATM Q13315 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
KDM1A O60341 1/20 0.32
PDK2 Q15119 2/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
ABCG2 Q9UNQ0 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
ABCB1 P08183 1/20 0.31
NPC1 O15118 1/20 0.31
XBP1 P17861 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17151901 0.99 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21416202 0.95 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17152019 0.94 RARB (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17151995 0.93 PDK2 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18386086 0.91 RARB (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17151882 0.91 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL13487548 0.89 MEN1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18819554 0.89 PDK2 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18819130 0.88 PDK2 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21416093 0.87 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024114-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2023-01-26 US disclosed
US-20220376178-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2022-11-24 US disclosed
US-10381572-B2 Heterocyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2019-08-13 US disclosed
US-20170018718-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-01-19 US disclosed
US-20170018718-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-01-19 US disclosed
WO-2015152651-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10381572-B2 Heterocyclic compound and organic light-emitting element comprising same CRY1, CRY2, PER2 MEN1 822/4885KMT2A 518/4885MAPT 915/4885
US-20170018718-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 MEN1 822/4885KMT2A 518/4885MAPT 915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.